ASP7663

CAS No. 1190217-35-6

ASP7663 ( —— )

Catalog No. M21597 CAS No. 1190217-35-6

ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 51 Get Quote
5MG 77 Get Quote
10MG 120 Get Quote
25MG 222 Get Quote
50MG 354 Get Quote
100MG 514 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ASP7663
  • Note
    Research use only not for human use.
  • Brief Description
    ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
  • Description
    ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRPA1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1190217-35-6
  • Formula Weight
    263.26
  • Molecular Formula
    C14H14FNO3?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)CN1C(=O)\C(=C\C(O)=O)c2cccc(F)c12
  • Chemical Name
    (2E)-2-[7-Fluoro-12-dihydro-1-(2-methylpropyl)-2-oxo-3H-indol-3-ylidene]acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kojima R Nozawa K Doihara H et al. Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain[J]. European Journal of Pharmacology 2014 723:288-293.
molnova catalog
related products
  • TRPM4 inhibitor 8

    TRPM4 inhibitor 8 is an inhibitor of Transient receptor potential melastatin 4(TRPM4) which contributes to viability, migration, cell cycle shift, and adhesion.

  • IA-Alkyne

    IA-Alkyne is a TRP channel (TRPC) agonist. IA-Alkyne can be used to develop an isotopically tagged probe for quantitative cysteine-reactivity profiling. It also has the potential for the study of respiratory infection.

  • GSK2193874

    GSK2193874 was identified as a selective orally active TRPV4 blocker.